Facebook
Twitter
Telegram
Fehler meldenTRACON Pharmaceuticals Kennzahlen 2011-2024 | TCON
Kennzahlen Jährlich TRACON Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.6 | -1.1 | -1.7 | -6.3 | -0.6 | -0.6 | -2.6 | -2.3 | -3.5 | -16.5 | - | - | - |
P/S |
0.5 | - | 138.1 | - | - | 7.3 | 5.7 | 17.6 | 10.7 | 31.3 | - | - | - |
EPS |
-0.1 | -1.4 | -1.7 | -1.9 | -7.5 | -13.0 | -11.4 | -2.1 | -2.2 | -4.4 | -4.9 | - | - |
EV (Enterprise Value) |
-2.67 M | 13.5 M | 23.7 M | 73 M | 11.9 M | 15.9 M | 39.3 M | 42.5 M | 66.1 M | 148 M | 25.5 M | 20.3 M | - |
EBITDA per Share |
-0.28 | -1.33 | -1.64 | -1.8 | -7.34 | -12.9 | -10.8 | -20.4 | -21.1 | -5.15 | - | - | - |
EV/EBITDA |
-0.4 | -4.3 | -0.1 | -0.1 | -1.5 | -1.3 | -2.2 | -13.3 | - | - | - | ||
PEG |
0.04 | 0.04 | 0.05 | 0.21 | -0.01 | 0.04 | -0.06 | -0.71 | 0.01 | -0.26 | - | - | - |
P/B |
0.6 | 1.6 | 1.8 | 2.8 | 4.8 | 1.0 | 2.9 | 2.1 | 2.7 | -3.5 | - | - | - |
P/CF |
1.6 | -1.2 | -2.1 | -6.2 | -0.5 | -0.7 | -3.7 | -2.2 | -4.4 | 66.7 | - | - | - |
ROE % |
443.51 | 407.43 | -244.72 | -66.91 | -840.40 | -163.04 | -112.46 | -95.31 | -78.80 | 21.16 | - | - | - |
ROA % |
-35.51 | -149.65 | -107.95 | -44.81 | -125.13 | -86.00 | -52.87 | -59.06 | -45.61 | -17.84 | - | - | - |
ROCE % |
1146.23 | 390.07 | -241.99 | -64.71 | -354.64 | -127.94 | -74.84 | -73.20 | -59.64 | -24.80 | - | - | - |
Current Ratio |
- | - | - | - | 1.5 | 3.0 | 3.1 | 4.5 | 3.8 | 2.7 | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Kennzahlen Vierteljährlich TRACON Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.33 | - | 0.29 | -0.2 | -6.76 | - | -0.3 | -0.31 | -0.48 | - | -0.38 | -0.58 | -0.33 | - | -0.38 | -0.7 | -0.78 | -1.25 | -1.74 | -2.11 | -2.41 | -2.6 | -3.04 | -3.28 | -4.59 | -0.37 | 0.07 | -0.4 | -0.44 | -0.45 | -0.48 | -0.68 | -0.54 | -0.91 | -0.53 | -0.24 | -0.5 | -1.64 | -1.23 | -0.65 | -0.88 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-1.34 | - | - | - | -5.81 | - | -0.3 | -0.31 | -0.48 | - | -0.37 | -0.57 | -0.32 | - | -0.37 | -0.67 | -0.75 | - | -1.69 | -2.08 | -2.39 | - | -0.3 | -0.33 | -0.45 | - | 0.08 | -0.38 | -0.43 | - | -0.46 | -0.65 | -0.51 | - | -0.51 | -0.22 | -0.46 | - | -1.05 | -0.55 | -0.82 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-478.25 | -232.25 | 11.96 | 605.17 | 810.31 | 149.76 | 112.91 | -168.16 | -488.27 | -136.75 | -152.68 | -131.74 | -74.47 | -49.71 | -195.60 | -372.37 | -589.09 | -840.40 | -730.69 | -580.36 | -391.38 | -163.04 | -165.49 | -116.23 | -109.39 | -112.46 | -96.12 | -123.73 | -114.36 | -95.31 | -108.69 | -108.78 | -88.93 | -78.90 | -35.31 | -8.54 | 3.94 | 21.16 | 13.24 | 7.28 | 4.23 | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
143.25 | -39.40 | -72.12 | -219.18 | -207.36 | -122.68 | -143.87 | -132.34 | -125.95 | -70.54 | -81.20 | -70.67 | -49.21 | -33.29 | -55.01 | -73.04 | -96.06 | -125.13 | -122.49 | -116.15 | -105.23 | -86.00 | -85.08 | -59.49 | -53.67 | -52.87 | -48.52 | -64.60 | -64.57 | -59.06 | -65.89 | -65.10 | -52.41 | -45.67 | -31.70 | -24.68 | -21.79 | -17.84 | -11.16 | -6.13 | -3.57 | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
290.23 | 122.49 | 364.50 | 555.02 | 795.51 | 148.88 | 112.40 | -166.09 | -485.78 | -135.08 | -150.43 | -129.30 | -72.24 | -48.05 | -236.37 | -409.35 | -623.42 | -685.10 | -727.46 | -581.50 | -395.63 | -125.96 | -117.76 | -67.19 | -59.04 | -69.79 | -89.55 | -117.51 | -108.51 | -70.23 | -90.36 | -90.73 | -71.13 | -40.77 | -35.48 | -10.06 | 1.37 | 12.20 | 12.20 | 6.91 | 4.14 | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung